Dr Bauml discusses how he and his lung cancer patients have adapted during this unprecedented time.
Mary-Elizabeth Percival, MD, outlines considerations for treating patients with hematologic malignancies during the COVID-19 pandemic.
Kristin Higgins, MD, Winship Cancer Institute, shares how the treatment of patients with lung cancer has been impacted by the COVID-19 pandemic.
John Allan, MD, explains the impact the COVID-19 pandemic has had on the treatment of patients with follicular lymphoma and other indolent lymphomas.
Findings from a clinical trial of patients with WM suggest that ibrutinib may protect against lung injury and improve pulmonary function in hypoxic patients with COVID-19.
Dr Raje shares her personal story with COVID-19, considerations when caring for those who have contracted the virus, and some insight on how oncology care has changed during this era.
Mehdi Hamadani, MD, discusses the impact the global pandemic has had on bone marrow and stem cell transplantation for patients with blood cancers.
Joshua Bauml, MD, shares first-hand insight on the management of lung cancer during the COVID-19 pandemic.
Stay in the know.
OncNet Newsletter